Beijing Tiantan Biological Products (SHSE:600161) Accounts Payable & Accrued Expense : ¥943 Mil (As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Accounts Payable & Accrued Expense?

Beijing Tiantan Biological Products's quarterly accounts payable & accrued expense declined from Sep. 2023 (¥1,192 Mil) to Dec. 2023 (¥894 Mil) but then increased from Dec. 2023 (¥894 Mil) to Mar. 2024 (¥943 Mil).

Beijing Tiantan Biological Products's annual accounts payable & accrued expense increased from Dec. 2021 (¥463 Mil) to Dec. 2022 (¥726 Mil) and increased from Dec. 2022 (¥726 Mil) to Dec. 2023 (¥894 Mil).

Beijing Tiantan Biological Products Accounts Payable & Accrued Expense Historical Data

The historical data trend for Beijing Tiantan Biological Products's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Accounts Payable & Accrued Expense Chart

Beijing Tiantan Biological Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

367.64

406.30

463.28

725.88

894.02

Beijing Tiantan Biological Products Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															862.65	1,008.46	1,192.41	894.02	942.72

Beijing Tiantan Biological Products Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Beijing Tiantan Biological Products (SHSE:600161) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024

Website

http://www.tiantanbio.com

Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.

Executives

Wang Jian Ming	Supervisors
Liu Ya Na	Directors, senior managers
Fu Dao Xing	Directors, senior managers
He Yan Lin	Directors, senior managers
Hu Li Gang	Director
Ci Xiang	senior management
Yang Hui Chuan	Director
Zhang Yi	senior management
Wu Zhen Shan	senior management

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines